Tag : genomics

Rob Brainin Named Executive Vice President and Chief Business Officer;Bill Zondler Appointed Senior Vice President and Chief Information Officer Veracyte, Inc. (Nasdaq: VCYT), a global genomic...

– Verge to Receive Up to $25M in Upfront, Equity Investment and Potential Near-Term Payments, with Additional Milestone Value of $694M and Potential Downstream Royalties – Collaboration...

Verge Genomics, a biotech company that has created an industry leading all-in-human, artificial-intelligence-powered drug discovery and development platform focused on therapies for serious genetic diseases,...

DermTech, Inc. (NASDAQ: DMTK) (“DermTech”), a leader in precision dermatology enabled by a non-invasive skin genomics platform, announced today the appointment of Monica Tellado, Senior Vice...

Dr. Harton to lead the translation of BioSkryb’s Primary Template-directed Amplification (PTA) technology into breakthrough diagnostic applications for targeted indications, including cancer and neurological disorders...

Veracyte (Nasdaq: VCYT), a global genomic diagnostics company, today announced key appointments that expand and further strengthen the company’s medical team. William A. Bulman, M.D. and...

Genomic Testing Cooperative, a first-in-class diagnostic company based on a cooperative business model (Co-Op) using the most recent advances in NGS technology, announced today a...

License agreement to enhance Nippon Gene’s CRISPR/Cas9 research reagents offering ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual...

To Support Global BioPharma Companies Leveraging Robust Single-Cell Technologies for Accelerated and Improved Drug Development Genuity Science, a genomics data, analytics and insights organization, today...

Personal Genome Diagnostics Inc. (PGDx) today announced a strategic collaboration with Massachusetts General Hospital (MGH). The two organizations will work closely on the development of...